94 related articles for article (PubMed ID: 26181663)
21. Peptide-specific engagement of the activating NK cell receptor KIR2DS1.
Chapel A; Garcia-Beltran WF; Hölzemer A; Ziegler M; Lunemann S; Martrus G; Altfeld M
Sci Rep; 2017 May; 7(1):2414. PubMed ID: 28546555
[TBL] [Abstract][Full Text] [Related]
22. KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.
Erbe AK; Diccianni MB; Mody R; Naranjo A; Zhang FF; Birstler J; Kim K; Feils AS; Hung JT; London WB; Shulkin BL; Mathew V; Parisi MT; Servaes S; Asgharzadeh S; Maris JM; Park J; Yu AL; Sondel PM; Bagatell R
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822669
[TBL] [Abstract][Full Text] [Related]
23. The role of Killer immunoglobulin-like receptors (KIRs) in the genetic susceptibility to non-celiac wheat sensitivity (NCWS).
Gambino CM; Agnello L; Vidali M; Lo Sasso B; Mansueto P; Seidita A; Giuliano A; Scazzone C; Massa D; Masucci A; Tamburello M; Vassallo R; Ciaccio AM; Candore G; Carroccio A; Ciaccio M
Clin Chem Lab Med; 2024 Apr; ():. PubMed ID: 38639193
[TBL] [Abstract][Full Text] [Related]
24. The relation between activator and inhibitor killer-cell immunoglobulin-like receptors and hepatotoxicity in oncological treatment.
Urrutia-Maldonado E; Alés-Palmer M; Muñoz DE Rueda P; Peláez-Pleguezuelos I; Ocete-Hita E
Minerva Pediatr (Torino); 2023 Oct; 75(5):668-673. PubMed ID: 31264397
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer.
Shiravani Z; Mirshekari K; Larki MH; Shafiee N; Haghshenas MR; Ghaderi A; Fattahi MJ
J Reprod Immunol; 2024 Mar; 162():104217. PubMed ID: 38387251
[TBL] [Abstract][Full Text] [Related]
26. Underrepresentation of activating KIR gene expression in single-cell RNA-seq data is due to KIR gene misassignment.
Alves E; Chopra A; Ram R; Currenti J; Kalams SA; Mallal SA; Phillips EJ; Gaudieri S
Eur J Immunol; 2024 Jan; 54(1):e2350590. PubMed ID: 37944995
[TBL] [Abstract][Full Text] [Related]
27. HLA-G isoforms, HLA-C allotype and their expressions differ between early abortus and placenta in relation to spontaneous abortions.
Bora M; Singha S; Madan T; Deka G; Hazarika SG; Baruah S
Placenta; 2024 Apr; 149():44-53. PubMed ID: 38492472
[TBL] [Abstract][Full Text] [Related]
28. Is the Development of Ascites in Alcoholic Liver Patients Influenced by Specific KIR/HLA Gene Profiles?
Legaz I; Morales R; Bolarín JM; Collados-Ros A; Pons JA; Muro M
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760846
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of patients in their forties who underwent surgical resection for colorectal cancer in Korea.
Lee CS; Baek SJ; Kwak JM; Kim J; Kim SH
World J Gastroenterol; 2021 Jul; 27(25):3901-3912. PubMed ID: 34321853
[TBL] [Abstract][Full Text] [Related]
30. The KIR2DL1 intermediate upstream element participates in gene activation.
Wright PW; Li H; Rahman MA; Anderson EM; Karwan M; Carrell J; Anderson SK
Immunogenetics; 2023 Dec; 75(6):495-506. PubMed ID: 37801092
[TBL] [Abstract][Full Text] [Related]
31. The KIR2DL family serves as prognostic biomarkers and correlates with immune infiltrates in acute myeloid leukaemia.
Liu W; Zhu M; Li G; Xi Y
J Cell Mol Med; 2024 Apr; 28(8):e18256. PubMed ID: 38527290
[TBL] [Abstract][Full Text] [Related]
32. NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis.
Fionda C; Scarno G; Stabile H; Molfetta R; Di Censo C; Gismondi A; Paolini R; Sozzani S; Santoni A; Sciumè G
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887206
[TBL] [Abstract][Full Text] [Related]
33. KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.
Blunt MD; Vallejo Pulido A; Fisher JG; Graham LV; Doyle ADP; Fulton R; Carter MJ; Polak M; Johnson PWM; Cragg MS; Forconi F; Khakoo SI
J Immunol; 2022 Jul; 209(2):379-390. PubMed ID: 35768150
[TBL] [Abstract][Full Text] [Related]
34. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
[TBL] [Abstract][Full Text] [Related]
35. Killer immunoglobulin-like receptors/human leukocyte antigen class-I, a crucial immune pathway in cancer.
Xu Y; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; Ye L; He Y; Zhou C
Ann Transl Med; 2020 Mar; 8(5):244. PubMed ID: 32309391
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer.
Diaz-Peña R; Mondelo-Macía P; Molina de la Torre AJ; Sanz-Pamplona R; Moreno V; Martín V
Cells; 2020 Feb; 9(2):. PubMed ID: 32102404
[TBL] [Abstract][Full Text] [Related]
37. Killer Immunoglobulin-Like Receptor-Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations.
Krieger E; Sabo R; Moezzi S; Cain C; Roberts C; Kimball P; Chesney A; McCarty J; Keating A; Romee R; Wiedl C; Qayyum R; Toor A
Biol Blood Marrow Transplant; 2020 Apr; 26(4):672-682. PubMed ID: 31676338
[TBL] [Abstract][Full Text] [Related]
38. Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy.
Chrétien S; Zerdes I; Bergh J; Matikas A; Foukakis T
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31060337
[TBL] [Abstract][Full Text] [Related]
39. Cancer treatment and the KIR-HLA system: an overview.
Leone P; De Re V; Vacca A; Dammacco F; Racanelli V
Clin Exp Med; 2017 Nov; 17(4):419-429. PubMed ID: 28188495
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer and the
Ghanadi K; Shayanrad B; Ahmadi SA; Shahsavar F; Eliasy H
Genom Data; 2016 Dec; 10():118-126. PubMed ID: 27843767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
